Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

HIMS Hims & Hers Health Inc.

交易中 12-16 15:10:45 EST

36.39

+0.14

+0.39%

最高36.90	最低35.41	成交量760.25万
今开35.86	昨收36.25	日振幅4.11%
总市值82.84亿	流通市值71.87亿	总股本2.28亿
成交额2.74亿	换手率3.85%	流通股本1.98亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"HIMS","market":"US","secType":"STK","nameCN":"Hims & Hers Health Inc.","latestPrice":36.39,"timestamp":1765915842766,"preClose":36.25,"halted":0,"volume":7602525,"delay":0,"floatShares":197512273,"shares":227648514,"eps":0.536861,"marketStatus":"交易中","change":0.14,"latestTime":"12-16 15:10:45 EST","open":35.8633,"high":36.9,"low":35.41,"amount":274214751.985125,"amplitude":0.041103,"askPrice":36.41,"askSize":64,"bidPrice":36.39,"bidSize":45,"shortable":3,"etf":0,"ttmEps":0.536861,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"exchange":"NYSE","adjPreClose":36.25,"preHourTrading":{"tag":"盘前","latestPrice":35.92,"preClose":36.25,"latestTime":"09:29 EST","volume":52692,"amount":1895317.434696,"timestamp":1765895398700},"postHourTrading":{"tag":"盘后","latestPrice":35.9236,"preClose":36.25,"latestTime":"19:59 EST","volume":572659,"amount":20756778.4531,"timestamp":1765846796538},"volumeRatio":0.713359,"optionData":{"bulkOrders":[{"symbol":"HIMS","call":false,"expireDate":1766120400000,"strike":"45.0","timestamp":1765911078374,"price":8.85,"volume":3350,"amount":2964750,"type":"-"}]},"impliedVol":0.7397,"impliedVolPercentile":0.004},"requestUrl":"/m/hq/s/HIMS","defaultTab":"news","newsList":[{"id":"1148188055","title":"Hims & Hers Health宣布正式进军加拿大市场，盘前股价涨超3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1148188055","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148188055?lang=zh_cn&edition=full","pubTime":"2025-12-04 22:16","pubTimestamp":1764857781,"startTime":"0","endTime":"0","summary":"12月4日，健康与保健平台$Hims & Hers Health(HIMS)$宣布正式扩展至加拿大市场，标志着其国际增长战略的重要一步。该公司最近收购了专注于减肥治疗的加拿大数字健康平台Livewell，这一战略举措使公司能够在明年在加拿大推出其全面的减肥计划，与预期的仿制司美格鲁肽上市时间相吻合。为支持这一新市场，Hims & Hers已任命Austin Kouri为加拿大区总经理，Dr. Sandy Van为加拿大首席医疗官。受此消息影响，Hims & Hers Health盘前股价涨超3%。","market":"us","thumbnail":"https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/df4ec61541b268a5353585001973d7cb"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0fff7c28e47f2654bd0c3c168eaf70b6","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers Health宣布正式进军加拿大市场","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"gpt_icon":0},{"id":"1117683379","title":"异动解读 | 业绩超预期 Hims & Hers Health夜盘大涨12.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=1117683379","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117683379?lang=zh_cn&edition=full","pubTime":"2025-11-05 09:11","pubTimestamp":1762305061,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health周二夜盘大涨12.15%，引发投资者广泛关注。该涨幅主要受益于公司发布的强劲第三季度财报。根据Hims & Hers Health公布的最新财报，公司第三季度营收超过分析师平均预期的5.802亿美元。用户数量增长强劲，达到247万，同比增长21%。值得注意的是，Hims & Hers Health的股价今年以来表现亮眼。截至上一个交易日，该公司股价已累计上涨83.6%。这次强劲的季度业绩进一步增强了投资者对公司增长前景的信心，推动股价在夜盘交易中大幅攀升。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"1157221139","title":"异动解读 | 业绩超预期，Hims & Hers Health盘中大涨5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=1157221139","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157221139?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:56","pubTimestamp":1762268205,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health今日盘中股价大涨5.16%，引起投资者广泛关注。该公司周一晚间发布的第三季度财报显示业绩超出市场预期，成为推动股价上涨的主要因素。根据公司公布的财报，Hims & Hers Health第三季度营收超过分析师平均预期的5.802亿美元。用户数量增长强劲，达到247万，同比增长21%。值得注意的是，Hims & Hers Health的股价今年以来表现亮眼。截至上一个交易日，该公司股价已累计上涨83.6%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"1115165000","title":"异动解读 | Hims & Hers Health夜盘大涨5.45%，第三季度业绩超预期，正与诺和诺德洽谈合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1115165000","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1115165000?lang=zh_cn&edition=full","pubTime":"2025-11-04 09:03","pubTimestamp":1762218194,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health周一夜盘大涨5.45%，主要受益于公司发布的第三季度财报显示业绩超出市场预期。根据公司公布的财报，Hims & Hers Health第三季度实现营收6亿美元，超过分析师预期的5.802亿美元，同比增长49%。此外，公司2025年第三季度调整后EBITDA为7840万美元，较去年同期的5110万美元有显著增长。值得注意的是，Hims & Hers Health正在与诺和诺德积极洽谈，以便通过其平台提供Wegovy注射剂和口服Wegovy。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6b43f5868e1a5ac8f736ff2144c2c120","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":1},{"id":"1146378774","title":"HIMS Q3营收同比增长49%，调整后EBITDA大幅攀升，股价盘后涨超5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146378774","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146378774?lang=zh_cn&edition=full","pubTime":"2025-11-04 06:55","pubTimestamp":1762210523,"startTime":"0","endTime":"0","summary":"展望未来，Hims & Hers预计2025年第四季度的营收将在6.05亿美元至6.25亿美元之间，调整后EBITDA为5500万美元至6500万美元，调整后EBITDA利润率预计为9%至10%。对于2025年全年，公司预计营收将在23.35亿美元至23.55亿美元之间，调整后EBITDA为3.07亿美元至3.17亿美元，调整后EBITDA利润率预计为13%。受财报影响，Hims & Hers Health盘后股价涨超5%。","market":"us","thumbnail":"https://static.tigerbbs.com/04d0654d12d8106ec177c462b61be25d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/04d0654d12d8106ec177c462b61be25d"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6b43f5868e1a5ac8f736ff2144c2c120","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"HIMS Q3营收同比增长49%，调整后EBITDA大幅攀升，股价盘后涨超5%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","BK4196"],"gpt_icon":1},{"id":"1106598010","title":"异动解读 | Hims & Hers Health盘后大涨6.65%，第三季度业绩超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1106598010","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106598010?lang=zh_cn&edition=full","pubTime":"2025-11-04 05:34","pubTimestamp":1762205660,"startTime":"0","endTime":"0","summary":"远程医疗公司Hims & Hers Health周一盘后股价大涨6.65%，引发市场关注。该公司发布的第三季度财报显示业绩超出市场预期，强劲的用户增长和收入表现成为推动股价上涨的主要因素。根据公司公布的财报，Hims & Hers Health第三季度实现营收6亿美元，超过分析师预期的5.802亿美元。此外，市场消息显示，Hims & Hers Health正在积极讨论通过其平台提供Wegovy注射剂和诺和诺德的口服Wegovy。这一举措可能进一步扩大公司的业务范围，为未来增长提供新的动力。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6b43f5868e1a5ac8f736ff2144c2c120","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"1179258684","title":"Hims \\u0026 Hers Health正在积极讨论通过其平台提供Wegovy注射剂和诺和诺德的口服Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=1179258684","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179258684?lang=zh_cn&edition=full","pubTime":"2025-11-04 05:06","pubTimestamp":1762203989,"startTime":"0","endTime":"0","summary":"Hims \\u0026 Hers Health正在积极讨论通过其平台提供Wegovy注射剂和诺和诺德的口服Wegovy。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"1125260631","title":"财报前瞻 | 订阅韧性与GLP-1再平衡，市场预期Hims & Hers Health三季度经调整每股收益下跌44%","url":"https://stock-news.laohu8.com/highlight/detail?id=1125260631","media":"财报Agent","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125260631?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:34","pubTimestamp":1761644063,"startTime":"0","endTime":"0","summary":"$Hims & Hers Health Inc.$将于11月3日发布2025年第三季度财报。市场预测根据彭博数据，市场一致预期Hims & Hers Health第三季度收入将同比增长44%至5.8亿美元。经调整每股收益则下跌44%至0.24美元。上季度回顾Hims&Hers Health第二季度净利润为4250万美元，略低于IBES的预期。体重管理的价格与合规再平衡体重管理与GLP-1相关业务是近两季争议焦点。整体来看，市场主流以中性至谨慎为基准，关注三季度收入增速、毛利率的区间执行以及每股收益的延续改善。","market":"us","thumbnail":"https://community-static.tradeup.com/news/9dc1007f816510983d028293aeb7c687","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/9dc1007f816510983d028293aeb7c687"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"gpt_icon":1},{"id":"1196594336","title":"异动解读 | Hims & Hers Health盘中大跌13.05%，新业务拓展未能支撑股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1196594336","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1196594336?lang=zh_cn&edition=full","pubTime":"2025-10-17 23:44","pubTimestamp":1760715881,"startTime":"0","endTime":"0","summary":"周五盘中，Hims & Hers Health Inc.股价大跌13.05%，引发市场关注。这一跌势延续了该公司近日的股价波动，抹去了本周早些时候的涨幅。从本周走势来看，Hims & Hers Health股价经历了较大幅度的起伏。在消息面上，Hims & Hers Health近期宣布为围绝经期和更年期人群推出价格亲民的治疗方案，将业务范围拓展至激素替代疗法领域。然而，这一积极消息似乎未能支撑股价，反而可能引发了投资者对公司扩张策略的质疑。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":1},{"id":"1182556610","title":"异动解读 | Hims & Hers Health盘中大跌13.05%，新业务消息未能提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1182556610","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182556610?lang=zh_cn&edition=full","pubTime":"2025-10-17 23:44","pubTimestamp":1760715878,"startTime":"0","endTime":"0","summary":"Hims & Hers Health今日盘中大跌13.05%，引发市场关注。这一跌幅延续了该股近日的下跌趋势，两天累计下跌已达15%，抹去了之前的涨幅。消息面上，Hims & Hers Health近期宣布为处于围绝经期和更年期的人群推出价格亲民的治疗方案。股价的大幅下跌可能反映了市场对公司新业务潜力的怀疑，或者是对整体估值的重新评估。此外，可能还有其他未披露的因素影响了投资者情绪，导致了这次显著的股价调整。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"2576059256","title":"美股异动 | Hims&Hers Health(HIMS.US)跌超10% 两天累跌15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576059256","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576059256?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:30","pubTimestamp":1760711421,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，继周三大涨16%后，周五Hims&Hers Health(HIMS.US)跌超10%，两天累跌15%，一举抹去此前涨幅。消息面上，此前该公司宣布，已为处于围绝经期和更年期的人群推出价格亲民的治疗方案。此次更年期护理服务的推出，将该公司的业务范围拓展至激素替代疗法领域。Hims&Hers补充表示，预计这一新专项服务将助力其“Hers”部门在明年实现年营收超10亿美元的目标。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356671.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"1126486283","title":"Form 144 | Hims & Hers Health高管 Andrew Dudum 拟减持175,661股，总价约1,103万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126486283","media":"老虎公告助手","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126486283?lang=zh_cn&edition=full","pubTime":"2025-10-17 03:15","pubTimestamp":1760642110,"startTime":"0","endTime":"0","summary":"Hims & Hers Health的高管Andrew Dudum拟于美东时间2025年10月16日出售175,661股公司普通股票，总市值约为1,103万美元。此前3个月，Andrew Dudum曾多次减持其持有的公司股份。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Form 144 | Hims & Hers Health高管 Andrew Dudum 拟减持175,661股，总价约1,103万美元","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS"],"gpt_icon":0},{"id":"1171901481","title":"期权大单 | 芯片争夺白热化，AMD抢单英伟达大涨9%；HIMS与SMR涨超16%，期权交易火爆","url":"https://stock-news.laohu8.com/highlight/detail?id=1171901481","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171901481?lang=zh_cn&edition=full","pubTime":"2025-10-16 12:04","pubTimestamp":1760587466,"startTime":"0","endTime":"0","summary":"截至收盘，道指跌17.15点，跌幅为0.04%，报46253.31点；纳指涨148.38点，涨幅为0.66%，报22670.08点；标普500指数涨26.75点，涨幅为0.40%，报6671.06点。期权市场总成交量66,413,557张合约，其中看涨期权占比63%。净营收同比增长11%，达280.9亿美元，高于275.2亿美元的预期。10月24日到期的55美元的行权看涨期权交易量特别高，共有23,428份合约交易。","market":"us","thumbnail":"https://community-static.tradeup.com/news/ea9e66a8e56a8cce77b73418abb37fc5","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/ea9e66a8e56a8cce77b73418abb37fc5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"3d80f168eb7ae4c38a066a999e0ead98","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVDA","SMR","HIMS","AMD","BAC"],"gpt_icon":1},{"id":"2575769297","title":"Hims & Hers推出更年期及围绝经期治疗服务，单日大涨逾16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575769297","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575769297?lang=zh_cn&edition=full","pubTime":"2025-10-16 08:59","pubTimestamp":1760576366,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Hims & Hers Health宣布，已为处于围绝经期和更年期的人群推出价格亲民的治疗方案。此次更年期护理服务的推出，将该公司的业务范围拓展至激素替代疗法领域。Hims & Hers补充表示，预计这一新专项服务将助力其“Hers”部门在明年实现年营收超10亿美元的目标。该公司称，患者可在其平台上与医疗服务提供者协作，获取针对更年期及围绝经期的治疗方案，方案涵盖处方药、贴片或药膏等形式。","market":"us","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1355685.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Hims & Hers推出更年期及围绝经期治疗服务，单日大涨逾16%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HIMS"],"gpt_icon":0},{"id":"1162891255","title":"Hims & Hers进入更年期护理领域预计将促进客户增长","url":"https://stock-news.laohu8.com/highlight/detail?id=1162891255","media":"投资观察","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162891255?lang=zh_cn&edition=full","pubTime":"2025-10-16 01:04","pubTimestamp":1760547872,"startTime":"0","endTime":"0","summary":"1300 ET - Hims & Hers Health在更年期护理领域的扩展将帮助该远程医疗平台扩大客户基础，尽管市场竞争激烈，Leerink Partners分析师在一份报告中表示。分析师指出，与任何竞争一样，个性化、成本和保险覆盖等因素都将影响客户的采纳和增长。总体来看，该公司在其主导的减重专长以外扩展治疗领域标志着一种渐进的积极信号，尽管该部分业务可能仍然会继续驱动股票表现。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b6c529f474c195ef992de6d17c42f0dc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"1147816491","title":"Hims & Hers的更年期产品市场潜力被视为173亿美元机会","url":"https://stock-news.laohu8.com/highlight/detail?id=1147816491","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147816491?lang=zh_cn&edition=full","pubTime":"2025-10-16 00:56","pubTimestamp":1760547393,"startTime":"0","endTime":"0","summary":"1255 ET - Hims & Hers Health在更年期和围绝经期产品的扩展预计将迎来1730亿美元的市场潜力，花旗分析师在一份报告中表示。该估计假设约有60%的中年女性在经历更年期症状时会选择在线治疗，平均每月售价为107美元。他们表示，推出节奏可能与该公司的口服减重产品相似，预计到明年4月底或5月初时，将实现1亿美元的收入运行率。然而，由于市场规模较小，更年期产品的销售规模可能无法达到平台GLP-1产品的同等水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b6c529f474c195ef992de6d17c42f0dc","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HIMS","BK4196"],"gpt_icon":0},{"id":"2573927472","title":"美股部分AI医疗概念股走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2573927472","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573927472?lang=zh_cn&edition=full","pubTime":"2025-10-08 23:14","pubTimestamp":1759936446,"startTime":"0","endTime":"0","summary":"格隆汇10月8日｜Recursion Pharmaceuticals涨超8%，CRISPR Therapeutics涨近7%，Tempus Al涨超3%，Hims & Hers Health涨超2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008232557a4574674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008232557a4574674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4548","BK4588","CRSP","BK4556","BK4585","HIMS","RXRX","BK4609","LU1861559042.SGD","BK4196","BK4539","LU1861558580.USD","BK4611"],"gpt_icon":0},{"id":"2567489737","title":"美股异动 | 旗下减肥药宣传内容遭FDA警告，Hims & Hers Health跌超7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567489737","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567489737?lang=zh_cn&edition=full","pubTime":"2025-09-16 23:40","pubTimestamp":1758037210,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周二，Hims & Hers Health(HIMS.US)股价走低，截至发稿，该股跌超7%，报49.99美元。此前该公司因其关于“复合型司美格鲁肽”产品的宣传内容收到美国食品药品监督管理局(FDA)的正式警告信。FDA强调，复合型药物产品本身并未获得FDA批准，因此不得将其等同于经过临床试验和审批的标准药品。监管机构已要求Hims & Hers在15个工作日内提交整改措施，若未能有效应对相关问题，可能将面临包括扣押产品、发布禁令在内的法律制裁。","market":"hk","thumbnail":"https://static.tigerbbs.com/76824cd4c5b97eaacdaab63d96995a28","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/76824cd4c5b97eaacdaab63d96995a28"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4628dfc3b3ea9cefe051cc10bbeea5f8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1346032.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"美股异动 | 旗下减肥药宣传内容遭FDA警告 Hims & Hers Health(HIMS.US)跌超7%","news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4196","HIMS"],"gpt_icon":0},{"id":"1127885430","title":"异动解读 | Hims & Hers Health股价盘中大跌8%，FDA警告其减肥药宣传不当","url":"https://stock-news.laohu8.com/highlight/detail?id=1127885430","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1127885430?lang=zh_cn&edition=full","pubTime":"2025-09-16 23:24","pubTimestamp":1758036279,"startTime":"0","endTime":"0","summary":"周二盘中，Hims & Hers Health股价大幅下挫，跌幅高达8.12%。这一显著跌幅源于美国食品药品监督管理局就公司的\"复合型司美格鲁肽\"产品宣传内容发出正式警告信。据报道，FDA在警告信中强调，复合型药物产品本身并未获得FDA批准，因此不得将其等同于经过临床试验和审批的标准药品。这直接挑战了Hims & Hers Health在减肥药市场的营销策略，引发了投资者对公司未来业务发展的担忧。FDA已要求Hims & Hers在15个工作日内提交整改措施。","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"4628dfc3b3ea9cefe051cc10bbeea5f8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["HIMS"],"gpt_icon":0},{"id":"1195292298","title":"Hims & Hers Health Inc.盘前跌2.8% 美国FDA局长称其超级碗广告违反药物推广规定","url":"https://stock-news.laohu8.com/highlight/detail?id=1195292298","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195292298?lang=zh_cn&edition=full","pubTime":"2025-09-15 18:16","pubTimestamp":1757931375,"startTime":"0","endTime":"0","summary":"Hims & Hers Health Inc.股价盘前下跌2.8%，此前美国FDA局长表示该公司的超级碗广告违反了药物推广规定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","HIMS"],"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":-0.0734},{"period":"1month","weight":-0.0197},{"period":"3month","weight":-0.2877},{"period":"6month","weight":-0.4064},{"period":"1year","weight":0.2075},{"period":"ytd","weight":0.4992}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Hims & Hers Health Inc是一家多专业远程医疗平台，将消费者与持牌医疗保健专业人员联系起来，使他们能够获得与心理健康、性健康、皮肤病学、头发护理等相关的多种疾病的高质量医疗服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.14307},{"month":2,"riseRate":0.666667,"avgChangeRate":0.154354},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.058791},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.029824},{"month":5,"riseRate":0.5,"avgChangeRate":0.191652},{"month":6,"riseRate":0.666667,"avgChangeRate":-0.021115},{"month":7,"riseRate":0.666667,"avgChangeRate":0.073238},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.14623},{"month":9,"riseRate":0.5,"avgChangeRate":0.080437},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.073266},{"month":11,"riseRate":0.714286,"avgChangeRate":0.187933},{"month":12,"riseRate":0.428571,"avgChangeRate":0.012096}],"exchange":"NYSE","name":"Hims & Hers Health Inc.","nameEN":"Hims & Hers Health Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Hims & Hers Health Inc.,HIMS,Hims & Hers Health Inc.股票,Hims & Hers Health Inc.股票老虎,Hims & Hers Health Inc.股票老虎国际,Hims & Hers Health Inc.行情,Hims & Hers Health Inc.股票行情,Hims & Hers Health Inc.股价,Hims & Hers Health Inc.股市,Hims & Hers Health Inc.股票价格,Hims & Hers Health Inc.股票交易,Hims & Hers Health Inc.股票购买,Hims & Hers Health Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Hims & Hers Health Inc.(HIMS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Hims & Hers Health Inc.(HIMS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}